New targeted cancer therapies have emerged to fight tumors, and scientists have much more in the pipeline.

Summary: New targeted cancer therapies have been highlighted this month as emerging technologies to fight tumors, and scientists have much more in the pipeline. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

Targeted cancer therapies – the most famous of which are immunotherapies such as CAR T-cell therapy – are the current focus of excitement in cancer treatment. New therapies and developments in the immunotherapy field prompted the National Cancer Institute (NCI) to update their guidance on targeted cancer therapies a little over a week ago. As the NCI says.

“Many targeted cancer therapies have been approved by the Food and Drug Administration (FDA) to treat specific types of cancer.”

Summary: Cancer immunotherapy treatments and other approaches to cure nearly all cancers within 8 years says Dr. Gilliland, a prominent cancer research head. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

Gary Gilliland, M.D., Ph.D. is the President and Director, Fred Hutchinson Cancer Research Center and in an opinion piece published at the beginning of this month, writes.

“I’ve gone on record to say that by 2025, cancer researchers will have developed curative therapeutic approaches for most if not all cancers.”

Team paves the way for cancer immunotherapy demonstrating a novel technique that attacked tumors and inhibited cancers from spreading.

Summary: Team paves the way for cancer immunotherapy with a novel technique that attacked tumors and inhibited cancers from spreading. [This article first appeared on LongevityFacts. Author: Brady Hartman. ]

While cancer immunotherapy is a powerful treatment for some types of tumors, up until now, it hasn’t worked well on colon cancer.

However, a team of researchers in Barcelona just showed a new technique that allows the immune system to recognize and begin fighting the tumor in mice. The treatment was so successful that it inhibited the tumors from spreading, or metastasizing to other parts of the body – as cancer is prone to do. Moreover, for those cancers that had already spread, the treatment enabled the immune system to eliminate them quickly.

The Undoing Aging 2018 Conference is coming to Berlin to discuss the science of rejuvenation biotech!

The SENS Research Foundation and the Forever Healthy Foundation have joined forces to host an exciting conference about rejuvenation biotechnology on March 15–17, 2018 at the Umspannwerk Alexanderplatz in Berlin, Germany.

A conference for everyone

The conference is open to the wider community interested in this field and anyone can attend. We believe that this is a fantastic move, as it allows more people to engage with the science and to learn firsthand from the researchers working on the front line. We very much support the idea that we are all in this together and thus are delighted to see that the event is open to the entire community.